Similarly, these factors that enforce this “molecular handbrake” in naive CD8+ T cells could represent potential targets of novel therapeutic strategies for the treatment of autoimmune disease in order to re-establish the quiescent program and limit disease. Here, CD8A is linked to autoimmune disease.